home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.410 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

35 36 Next >

Ocugen Announces Encouraging Data From Late-Stage COVID-19 Vaccine Study ↗

January 09, 2023

Via Benzinga

Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met

January 09, 2023

From Ocugen

Via GlobeNewswire

Why Shares of Ocugen Jumped Thursday ↗

December 29, 2022

Could short-sellers be enacting a squeeze?

Via The Motley Fool

7 Hot Meme Stocks of 2022 to Sell Before 2023 ↗

December 25, 2022

The value of most of the meme stocks have plunged, but there are still many meme stocks to sell at this point.

Via InvestorPlace

Why Ocugen Stock Wilted on Wednesday ↗

November 09, 2022

A prognosticator got less bullish on the company's prospects, and investors took this to heart.

Via The Motley Fool

Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

OCGN earnings call for the period ending September 30, 2022.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

Why Is Agrify (AGFY) Stock Down 50% Today? ↗

December 16, 2022

Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering.

Via InvestorPlace

OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial ↗

December 16, 2022

OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation.

Via InvestorPlace

Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®

December 16, 2022

Important next step for Ocugen’s regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell

December 13, 2022

From Ocugen

Via GlobeNewswire

7 Tech Stocks to Sell Before They Topple in 2023 ↗

December 08, 2022

It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued.

Via InvestorPlace

Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis

December 07, 2022

From Ocugen

Via GlobeNewswire

Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit

November 28, 2022

From Ocugen

Via GlobeNewswire

3 Stocks to Avoid Right Now ↗

November 17, 2022

Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

Via The Motley Fool

Why Ocugen Stock Popped by 7% on Tuesday ↗

November 08, 2022

A third-quarter report, complete with clinical updates, is more than enough to satisfy the biotech's bulls.

Via The Motley Fool

SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 08, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Ocugen Provides Business Update & Third Quarter 2022 Financial Results

November 08, 2022

From Ocugen

Via GlobeNewswire

Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗

November 08, 2022

Gainers

Via Benzinga

3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street ↗

November 02, 2022

Select analysts and pundits foresee game-changing upside from this fast-paced trio.

Via The Motley Fool

Warning! Don’t Even Consider Buying These 7 Dead-Money Stocks ↗

November 01, 2022

These dead-money stocks exhibit incredible volatility and present themselves as remarkably risky bets in this current economic environment.

Via InvestorPlace

Ocugen to Host Conference Call on Tuesday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2022 Financial Results

October 27, 2022

From Ocugen

Via GlobeNewswire

Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022

October 19, 2022

From Ocugen

Via GlobeNewswire

What Happened With Ocugen Shares During Wednesday's After-Hours Session ↗

October 12, 2022

Ocugen Inc (NASDAQ: OCGN) shares traded marginally higher by 1.22% at $1.66 during Wednesday's after-hours session.

Via Benzinga

Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2

October 12, 2022

From Ocugen

Via GlobeNewswire

What Is Going on With AMTD Digital (HKD) Stock Today? ↗

October 12, 2022

HKD stock is soaring for a second day. Since no major news about the company was reported, it appears that the stock has become a meme play.

Via InvestorPlace

Why Missfresh Shares Are Trading Lower; Here Are 30 Stocks Moving Premarket ↗

October 10, 2022

Gainers M-tron Industries, Inc. (NASDAQ: MPTI) rose 57.9% to $24.00 in pre-market trading after surging 10% on Friday. M-tron Industries completed its earlier announced separation from The LGL Group,...

Via Benzinga

Wall Street Thinks This Top 100 Robinhood Stock Could Skyrocket by 217% ↗

October 06, 2022

Can this vaccine maker turn things around?

Via The Motley Fool

Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences

October 06, 2022

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference

September 29, 2022

From Ocugen

Via GlobeNewswire

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com